STOCKHOLM, Oct. 25, 2023 /PRNewswire/ Annexin Pharmaceuticals announces that all patients in the first dose group with the lowest dose have now completed treatment in the company s clinical phase.
USACE re-awards contract to dismantle SM-1A reactor - Nuclear Engineering International neimagazine.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from neimagazine.com Daily Mail and Mail on Sunday newspapers.
EQS-News: Heidelberg Pharma AG: Interim Management Statement on the First Nine Months of 2023 finanzen.ch - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanzen.ch Daily Mail and Mail on Sunday newspapers.
EQS-News: Heidelberg Pharma AG / Key word: 9 Month figures
Heidelberg Pharma AG: Interim Management Statement on the First Nine Months of 2023
12.10.2023 /.
EQS-News: Heidelberg Pharma AG / Key word(s): 9 Month figuresHeidelberg Pharma AG: Interim Management Statement on the First Nine Months of 2023 12.10.2023 / 07:09 CET/CESTThe issuer is solely responsible for the content of this announcement.Heidelberg Pharma AG: Interim Management Statement on the First Nine Months.